CINECA IRIS Institutional Research Information System

DI PAOLO, ANTONELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.077
AS - Asia 6.976
EU - Europa 5.537
SA - Sud America 1.179
AF - Africa 342
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 3
Totale 31.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.605
SG - Singapore 2.154
CN - Cina 1.997
IT - Italia 1.946
HK - Hong Kong 1.192
BR - Brasile 1.003
SE - Svezia 913
DE - Germania 516
BG - Bulgaria 483
VN - Vietnam 388
GB - Regno Unito 374
CA - Canada 335
TR - Turchia 305
FI - Finlandia 251
RU - Federazione Russa 231
FR - Francia 202
IN - India 199
UA - Ucraina 158
KR - Corea 151
JP - Giappone 108
CI - Costa d'Avorio 100
BD - Bangladesh 78
BE - Belgio 72
MX - Messico 65
NL - Olanda 65
AR - Argentina 58
ZA - Sudafrica 58
CH - Svizzera 56
IQ - Iraq 52
PL - Polonia 48
SA - Arabia Saudita 45
UZ - Uzbekistan 44
GR - Grecia 41
ID - Indonesia 39
NG - Nigeria 39
PK - Pakistan 39
ES - Italia 38
EG - Egitto 32
AT - Austria 31
EC - Ecuador 26
AU - Australia 25
CO - Colombia 25
IR - Iran 23
IE - Irlanda 22
SN - Senegal 22
MA - Marocco 20
DK - Danimarca 19
PY - Paraguay 18
TT - Trinidad e Tobago 16
VE - Venezuela 16
KE - Kenya 15
MY - Malesia 15
AE - Emirati Arabi Uniti 14
PH - Filippine 14
DZ - Algeria 13
JO - Giordania 13
TH - Thailandia 13
TN - Tunisia 13
CZ - Repubblica Ceca 12
LT - Lituania 12
CL - Cile 10
TW - Taiwan 10
KZ - Kazakistan 9
NP - Nepal 9
PE - Perù 9
BO - Bolivia 8
CR - Costa Rica 8
OM - Oman 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
PS - Palestinian Territory 7
RS - Serbia 7
BB - Barbados 6
HU - Ungheria 6
IL - Israele 6
NI - Nicaragua 6
JM - Giamaica 5
KG - Kirghizistan 5
KW - Kuwait 5
NO - Norvegia 5
PA - Panama 5
RO - Romania 5
BF - Burkina Faso 4
BJ - Benin 4
LB - Libano 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
CG - Congo 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
LK - Sri Lanka 3
MD - Moldavia 3
MN - Mongolia 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
Totale 31.088
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.783
Ashburn 1.642
Houston 1.610
Ann Arbor 1.492
Fairfield 1.433
Singapore 1.184
Hong Kong 1.178
Santa Clara 828
Dallas 811
Chandler 788
Seattle 626
Wilmington 504
Cambridge 492
Shanghai 486
Sofia 479
Milan 427
Beijing 417
San Jose 336
New York 332
Serra 294
Boardman 257
Ottawa 256
Princeton 231
Los Angeles 221
Lawrence 192
Hefei 179
Medford 174
Jacksonville 170
Izmir 159
Nanjing 137
Seoul 134
Dearborn 130
Des Moines 118
Munich 106
Dong Ket 103
Abidjan 100
London 97
Istanbul 90
Florence 88
Pisa 85
San Diego 82
Washington 82
Redondo Beach 80
Buffalo 77
Council Bluffs 76
Tokyo 76
The Dalles 71
Frankfurt am Main 70
Brussels 67
Columbus 67
São Paulo 67
Ho Chi Minh City 66
Rome 64
Helsinki 60
Redwood City 60
Boulder 58
Nanchang 58
Chicago 55
Hanoi 50
Kunming 49
Bern 48
Ogden 45
Turku 42
Rio de Janeiro 41
Lagos 38
Falls Church 37
Tashkent 37
Belo Horizonte 36
Shenyang 35
Pune 34
Changsha 33
Norwalk 33
Warsaw 33
Bremen 31
Hebei 29
Phoenix 26
Jiaxing 24
Lucca 23
Toronto 23
Dakar 22
Dhaka 21
Düsseldorf 21
Ankara 20
Guangzhou 20
Jüchen 20
Montreal 20
San Francisco 20
Curitiba 19
Stockholm 19
Vienna 19
Jakarta 18
Johannesburg 18
Nuremberg 18
Auburn Hills 17
Baghdad 17
Fuzhou 17
Mumbai 17
Cape Town 16
Denver 16
Riyadh 16
Totale 22.543
Salva come PNG Salva come JPEG
Nome #
DECONTAMINAZIONE CON GENTAMICINA ORALE NEI PAZIENTI CON COLONIZZAZIONE INTESTINALE DA KLEBSIELLA PNEUMONIAE PRODUTTRICE DI KPC IN CORSO DI EPIDEMIA 527
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity 341
Procedimento attuato per mezzo di un elaboratore per la determinazione dei tempi di ritenzione e dei valori di concentrazione di analiti in una miscela 268
A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma 263
Determination of mitotane and principal metabolite by a simple HPLC-UV method and its validation in human plasma sample 256
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference LC-MS/MS 241
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers 237
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 227
Gender, MGMT methylation, and levetiracetam plasma levels correlate with survival benefit in glioblastoma patients treated with adjuvant temozolomide: results from a non-interventional retrospective clinical study 224
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 223
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. 222
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 220
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study 218
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 214
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients 212
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part I 210
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 207
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 204
Pharmacogenetics in Oncology 203
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference Mass Spectrometry 203
Personalized medicine of monoclonal antibodies in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and beyond 203
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 201
5-Fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer 197
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib 194
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity 194
Determination of mitotane and metabolite by a simple HPLC-UV method and application in plasma samples 193
The role of thymidylate synthase as a molecular biomarker 191
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer 191
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients 191
Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily 190
Impact of locoregional approaches to liver metastases in patients with colorectal cancer 188
Chronic administration of suramin induces neurotoxicity in rats 188
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. 188
Fungicidal activity and PK/PD of caspofungin as tools to guide antifungal therapy in a fluconazole-resistant C. parapsilosis candidemia 187
Methods: For studying pharmacogenetic profiles of combination chemotherapeutic drugs 184
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 184
Autoimmune diseases and myeloid hematological disorders: a possible pathogenetic relationship 184
5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients 183
A case report of a TDM-guided optimization of mitotane for a safe and effective long-term treatment 183
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction 182
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 181
Linezolid in the central nervous system: Comparison between cerebrospinal fluid and plasma pharmacokinetics 178
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 178
Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges 178
ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview 178
Daptomycin concentrations in valve tissue and vegetation in patients with bacterial endocarditis 177
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer 177
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 177
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. 176
Appropriateness of repetitive therapeutic drug monitoring and laboratory turn around time 176
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells 175
Time-dependent Pharmacokinetics of 5-fluorouracil and association with treatment tolerability in the adjuvant setting of colorectal cancer 174
Serotonin syndrome and the T102-->C polymorphism of the 5-HT2A receptor: a case report 174
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 174
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 174
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 174
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction 173
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 172
The pharmacological bases of the antiangiogenic activity of paclitaxel 171
Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin 171
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World 171
Genotype A1/A2 associated with neuroleptic malignant syndrome 171
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 170
Different recommendations for daptomycin dosing over time in patients with severe infections 170
Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update 169
Predicting survival with artificial neural networks 169
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 169
Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid 169
Irinotecan in 5-fluorouracil-refractory colorectal cancer 168
Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity 168
Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis 168
Precision medicine in lymphoma by innovative instrumental platforms 167
Liposomal anticancer therapy: pharmacokinetic and clinical aspects 166
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 166
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma 166
Linezolid for endocarditis: a case series of 14 patients 164
Prediction of fluoropyrimidine toxicities by screening DPYD genetic variants. 163
Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: the relevance of concomitant systemic antibiotic therapy. 161
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: A preclinical study 161
Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell lines 159
Pharmacogenetic determinants of anti-cancer drug activity and toxicity 159
Pharmacogenetics of Antiangiogenic Therapy 158
Administration interval and daptomycin toxicity: a case report of rhabdomyolysis 158
A new HPLC-UV method compared with HPLC-MS for daptomycin levels in human plasma samples 158
Therapeutic monitoring of Piperacillin in ICU patients 158
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo. 157
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 156
Cardiovascular implantable electronic device endocarditis treated with daptomycin with or without transvenous removal 155
Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate 155
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer 154
Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer 153
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib 150
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients 150
Improved analysis of 5-Fluorouracil and 5,6-dihydro-5-Fluorouracil by HPLC with diode array detection for determination of cellular dihydropyrimidine dehydrogenase activity and pharmacokinetic profiling 150
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo 148
Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections 147
Combined FAMD and ANOVA investigation leads to significant association between the hOCT1/ABCB1 diplotype and both efficacy and tolerability in patients affected by chronic myeloid leukemia 146
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 145
Pharmacogenetics of BCR/ABL inhibitors in chronic myeloid leukemia 143
Prognostic value of CD133 caused by mutant K-Ras and B-Raf 142
Totale 18.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.111
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.020 0 0 0 0 0 0 76 167 200 160 109 308
2021/20222.361 69 134 90 128 378 385 86 125 93 95 131 647
2022/20232.747 390 318 181 232 301 410 39 210 453 22 168 23
2023/20242.101 229 237 253 123 269 371 95 104 51 50 87 232
2024/20257.093 41 243 78 344 700 694 595 403 662 842 720 1.771
2025/20264.827 465 931 887 722 740 667 415 0 0 0 0 0
Totale 31.671